%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%A7%D9%84%D9%83%D8%B1%D9%88%D9%85%D9%88%D8%B3%D9%88%D9%85_%D8%A5%D9%83%D8%B3_%D8%A7%D9%84%D9%87%D8%B4Martin-Bell_sindromuS%C3%ADndrome_X_fr%C3%A0gilCategory:Fragile_X_syndromeFragiles-X-Syndrom%CE%A3%CF%8D%CE%BD%CE%B4%CF%81%CE%BF%CE%BC%CE%BF_%CE%B5%CF%85%CE%B8%CF%81%CE%B1%CF%8D%CF%83%CF%84%CE%BF%CF%85_%CF%87%CF%81%CF%89%CE%BC%CE%B1%CF%84%CE%BF%CF%83%CF%8E%CE%BC%CE%B1%CF%84%CE%BF%CF%82_XFragile_X_syndromeFragila_X_sindromoS%C3%ADndrome_X_fr%C3%A1gilX_hauskorraren_sindrome%D8%B3%D9%86%D8%AF%D8%B1%D9%85_%D8%A7%DB%8C%DA%A9%D8%B3_%D8%B4%DA%A9%D9%86%D9%86%D8%AF%D9%87Fragile-X-oireyhtym%C3%A4Syndrome_de_l%27X_fragile%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_X_%D7%A9%D7%91%D7%99%D7%A8T%C3%B6r%C3%A9keny_X-szindr%C3%B3ma%D5%93%D5%AD%D6%80%D5%B8%D6%82%D5%B6_X_%D5%B0%D5%A1%D5%B4%D5%A1%D5%AD%D5%BF%D5%A1%D5%B6%D5%AB%D5%B7Sindrome_dell%27X_fragile%E8%84%86%E5%BC%B1X%E7%97%87%E5%80%99%E7%BE%A4%E1%83%9B%E1%83%A7%E1%83%98%E1%83%A4%E1%83%94_X_%E1%83%A1%E1%83%98%E1%83%9C%E1%83%93%E1%83%A0%E1%83%9D%E1%83%9B%E1%83%98%EC%B7%A8%EC%95%BD_X_%EC%A6%9D%ED%9B%84%EA%B5%B0Fragiele-X-syndroomFragilt_X-syndrom%E0%AC%AB%E0%AD%8D%E0%AC%B0%E0%AC%BE%E0%AC%9C%E0%AC%BE%E0%AC%87%E0%AC%B2_%E0%AC%8F%E0%AC%95%E0%AD%8D%E0%AC%B8_%E0%AC%B8%E0%AC%BF%E0%AC%A3%E0%AD%8D%E0%AC%A1%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%AEZesp%C3%B3%C5%82_%C5%82amliwego_chromosomu_XS%C3%ADndrome_do_X_fr%C3%A1gil%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%9C%D0%B0%D1%80%D1%82%D0%B8%D0%BD%D0%B0_%E2%80%94_%D0%91%D0%B5%D0%BB%D0%BBFragile_X_syndrome%D0%9C%D0%B0%D1%80%D1%82%D0%B8%D0%BD-%D0%91%D0%B5%D0%BB_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BCFragil_X-syndromet%E0%AE%A8%E0%AE%B2%E0%AE%BF%E0%AE%A8%E0%AF%8D%E0%AE%A4_%E0%AE%8E%E0%AE%95%E0%AF%8D%E0%AE%9A%E0%AF%81_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D%E0%AE%A4%E0%AF%8D%E0%AE%A4%E0%AF%8A%E0%AE%95%E0%AF%88%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%82%E0%B8%84%E0%B8%A3%E0%B9%82%E0%B8%A1%E0%B9%82%E0%B8%8B%E0%B8%A1%E0%B9%80%E0%B8%AD%E0%B8%81%E0%B8%8B%E0%B9%8C%E0%B9%80%E0%B8%9B%E0%B8%A3%E0%B8%B2%E0%B8%B0%E0%B8%9A%E0%B8%B2%E0%B8%87Frajil_X_sendromuH%E1%BB%99i_ch%E1%BB%A9ng_fragile_XQ221472X%E6%9F%93%E8%89%B2%E9%AB%94%E6%98%93%E8%A3%82%E7%97%87
about
Decisional Capacity and Informed Consent in Fragile X SyndromeA 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X SyndromePediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X SyndromeA Prospective Open-label Study of Aripiprazole in Fragile X SyndromeProtein Synthesis in the Brain of Patients With Fragile X SyndromeA PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric ConditionsEarly Check: Expanded Screening in NewbornsA Trial of Metformin in Individuals With Fragile X SyndromeTreatment of Disruptive Behaviors in Fragile X SyndromeTrial of Sertraline to Treat Children With Fragile X SyndromeBrain Connectivity in Neurodevelopmental Disorders in Response to TreatmentLong-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X SyndromeSafety and Efficacy of AFQ056 in Adolescent Patients With Fragile X SyndromeAcamprosate in Youth With Fragile X SyndromeSafety and Efficacy Study of Antioxidants for the Treatment of the Fragile X SyndromeClinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X SyndromePediatric Patients With Metabolic or Other Genetic DisordersCognitive Training for Fragile X SyndromeEffects of Social Gaze Training on Brain and Behavior in Fragile X SyndromeOpen Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXSA Study of OV101 in Individuals With Fragile X SyndromeMetformin in Children and Adults With Fragile X SyndromeDouble-blind Placebo Controlled Study of Oxytocin in Fragile X SyndromeSafety and Efficacy of AFQ056 in Adult Patients With Fragile X SyndromeRandomized Controlled Study of Donepezil in Fragile X SyndromeA Study of RO4917523 in Pediatric Patients With Fragile X SyndromeValidation of Saliva in the Esoterix Genetic Laboratories Fragile X AssayCitocoline for Treatment of FXTASGanaxolone Treatment in Children With Fragile X SyndromeA Study of RO4917523 in Patients With Fragile X SyndromeClinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)Trial of Minocycline to Treat Children With Fragile X SyndromeA Study With RO4917523 in Patients With Fragile X SyndromeAn Open Label Extension Study of STX209 in Subjects With Fragile X SyndromeRiluzole in Fragile X SyndromeBiomarker and DNA Collection in Subjects Participating in Protocol 22003The Natural History of Reproductive and Overall Health in Girls and Women With a Pre-Mutation in the FMR1 Gene; Creation of a Patient Registry
P1050
P6530
Systematic review of pharmacological treatments in fragile X syndromeTargeting fragile X.Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability DisordersSynaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X SyndromeMatrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome.Fragile X syndromeTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesFragile X syndrome: a review of clinical and molecular diagnoses.Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in HumansIncreasing our understanding of human cognition through the study of Fragile X Syndrome.Pathological plasticity in fragile X syndrome.Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis.Fragile X syndrome in Korea: a case series and a review of the literature.The challenges of clinical trials in fragile X syndrome.Mechanism of repeat-associated microRNAs in fragile X syndrome.Astrocytes and developmental plasticity in fragile X.A common STEP in the synaptic pathology of diverse neuropsychiatric disorders.Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.Brain morphology in autism and fragile X syndrome correlates with social IQ: first report from the Canadian-Swiss-Egyptian Neurodevelopmental Study.Neuroepigenetic mechanisms in disease.Cortisol and behavior in fragile X syndrome.FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome.Involvement and therapeutic potential of the GABAergic system in the fragile X syndrome.Brain anatomy, gender and IQ in children and adolescents with fragile X syndromeImpaired GABA Neural Circuits Are Critical for Fragile X Syndrome
P921
Q61862260-10700BBD-F4B0-46AC-84A9-7A12788F4A04Q61894668-852C93C7-4E5D-4625-B244-7A8CE0C41B87Q61902282-EE5D9792-D710-448E-A0CF-9931288ABDACQ61915258-C0D3D984-57F1-4F97-87AA-F46C7F04A913Q61921978-1FDDC25C-CF83-4A36-8621-97C954802F91Q61934778-07322ADD-A35D-43C2-A750-2712E0EFF1E6Q61980600-27BB48F9-7089-43B0-B5D7-89BFA23C99E5Q62025003-08AA7378-56BA-4A30-9BB7-59680518FB3EQ62811824-D62FEB7C-1C32-4EED-902A-FEA17661E5ADQ62821035-138E2DBC-36DC-473F-8B64-8018AA0FB6E7Q63321189-3D5CDDA9-3F25-4715-AE41-BBEFDAD5FC0BQ63334034-439A8BE5-CBE5-47D9-9C85-AC4592D35E0FQ63335574-FBA8EE06-E3A1-4E0E-81FB-9415A0F44260Q63336463-F940CB56-E0C1-4155-AA6A-7317931353DEQ63338029-60CF0DC2-520A-4326-8183-77C41D13C5F8Q63338173-0D085DAF-1A79-4BFE-8D78-E3413B10E591Q63394013-56CF2584-4ADD-4EB3-B07A-85FF20D91580Q63397590-4DDE00C6-7669-4A30-B62B-0203DE846F4EQ63577926-FAA6AF2A-A2E6-40CE-B238-0C9D3E66D8E0Q63577996-A2721A67-648A-4964-863C-D0F15EB3BE9BQ63578474-6E6C3B02-F4E9-45FB-A25B-79ECBD5F1824Q63585406-969E0408-B0B2-45F5-B0CE-1F9718BCEED0Q63598123-4C4FC914-C3FA-4848-BF49-7B7C9083895CQ63598460-1EC31C87-4A2F-4802-A26B-DFCCFF49FB69Q63818477-37C4ED86-41E2-4321-8AE0-9C40593050A6Q63818548-F48A0621-F8E1-4A3C-848E-5E9BA183DC67Q63830230-D063F289-5B7F-42FD-B927-DD0737D8E892Q63840443-F456422E-603C-4624-8D8E-2F0F70EBBFBAQ63842612-BF9F13CF-2613-4E8B-A1EA-ED4F5283CBE6Q64610120-38141E66-F56D-4913-9689-B974C42B8BBDQ64637656-3C39AEA9-7D08-4C1D-99BF-98F7ED689EA4Q64645581-0D892855-C83C-4D74-910E-62342E9B5E7DQ64647406-2B72ADC9-0E3F-4ACE-BAB7-569CC80DF162Q64648127-17818E3A-48FB-439B-A67A-9E8080B3636BQ64657076-498188F1-69C0-4D26-ACCC-D311607A3D81Q64659269-53C24A75-FEC7-4B40-899B-ABE879C75549Q64659562-4F7BB01A-66F2-4D47-BF9A-32B419E5A6BBQ64677339-65FB5D78-9234-47A5-B70A-7E1CD9F366E6Q64677832-4ACF1F98-FCFF-42B2-B8A8-ACCA0EC0D69FQ64678529-C55E9498-92CE-456E-B9C6-B1BA869A7D38
P1050
description
Erbkrankheit durch Mutation des X-Chromosoms
@de
choroba genetyczna z mutacją chromosomu X
@pl
congenital disorder of nervous system
@en
malattia congenita del sistema nervoso
@it
perinnöllinen sairaus
@fi
vrozená vada nervové soustavy
@cs
name
Fragiele-X-syndroom
@nl
Fragila X sindromo
@eo
Fragile X syndrome
@en-ca
Fragile-X
@nb
Fragile-X-oireyhtymä
@fi
Fragiles-X-Syndrom
@de
Fragiles-X-Syndrom
@de-ch
Frajil X sendromu
@tr
Hội chứng fragile X
@vi
Martin-Bell sindromu
@az
type
label
Fragiele-X-syndroom
@nl
Fragila X sindromo
@eo
Fragile X syndrome
@en-ca
Fragile-X
@nb
Fragile-X-oireyhtymä
@fi
Fragiles-X-Syndrom
@de
Fragiles-X-Syndrom
@de-ch
Frajil X sendromu
@tr
Hội chứng fragile X
@vi
Martin-Bell sindromu
@az
altLabel
FRAX
@it
FXS
@nn
Fragile X mental retardation syndrome
@en
Fragilis x szindróma
@hu
Marker X syndrome
@en
Martin-Bell syndrome
@en
Qırılğan X-xromosomu sindromu
@az
Sindrome X fragil
@es
Sindrome di Martin-Bell
@it
X fragile
@it
prefLabel
Fragiele-X-syndroom
@nl
Fragila X sindromo
@eo
Fragile X syndrome
@en-ca
Fragile-X
@nb
Fragile-X-oireyhtymä
@fi
Fragiles-X-Syndrom
@de
Fragiles-X-Syndrom
@de-ch
Frajil X sendromu
@tr
Hội chứng fragile X
@vi
Martin-Bell sindromu
@az